GLYSTALI
LIVE

Serial Number

97453092

Owner

Zydus Pharmaceuticals (USA) Inc.

Attorney

Anthony J. DiMarino

Filing Date

Jun 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GLYSTALI Trademark

Serial Number: 97453092

GLYSTALI is a trademark filed by Zydus Pharmaceuticals (USA) Inc. on June 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Zydus Pharmaceuticals (USA) Inc. (21 trademarks)

Suite 204
Princeton, NJ 08543

Entity Type: 03

Trademark Details

Filing Date

June 10, 2022

Registration Date

Not Registered

Published for Opposition

May 30, 2023

Goods & Services

Anti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations for the treatment and prevention of eye diseases and conditions; Pharmaceutical preparations for the treatment and prevention of heart rhythm disorders; Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of hypertension; Pharmaceutical preparations for the treatment and prevention of skin disorders; Pharmaceutical preparations for the treatment and prevention of cancer and tumors; Pharmaceutical preparations for the treatment and prevention of allergies; Pharmaceutical preparations for the treatment and prevention of bone diseases; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and asthma; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 13, 2026 EXRA
SOU EXTENSION 5 GRANTED
May 12, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 12, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Dec 15, 2025 EEXT
SOU EXTENSION 5 FILED
Dec 14, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jul 15, 2025 EX4G
SOU EXTENSION 4 FILED
Jul 14, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 14, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 7, 2025 EX3G
SOU EXTENSION 3 FILED
Jan 6, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 6, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 24, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 24, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 24, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 21, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 19, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 19, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 19, 2023 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 18, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 18, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 18, 2023 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 25, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 30, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 30, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 10, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 15, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 23, 2022 NWOS
NEW APPLICATION ENTERED
Jun 14, 2022 NWAP